Drug Approvals

How can the industry balance the need for faster drug approvals with the necessity of ensuring patient safety and efficacy?

Pharma's Almanac

Sustainability

How can pharma manufacturing align with green initiatives while maintaining efficiency and compliance?

Pharma's Almanac

Personalized

How do you see advances in personalized medicine reshaping patient care, and what are the key challenges and opportunities ahead?

Pharma's Almanac

Precision Medicine

Advancing Personalized Medicines and Precision Therapeutics

Thermo Fisher Scientific

Innovation

How is the pharmaceutical industry integrating innovations from adjacent industries to enhance drug development and production?

Pharma's Almanac

Lyophilization

Pioneering Innovation in Pharmaceutical Lyophilization

Thermo Fisher Scientific

Ophthalmology

The Shift from Early- to Late-Phase Ophthalmology Retina Market in 2024: Proactive Planning for Late-Stage Clinical Success

Tracey Roberts, MSHS; Jennifer Christiansen, Ph.D.; Debra Schaumberg, Sc.D., O.D., M.P.H.

PPD, part of Thermo Fisher Scientific

Cell and Gene Therapy

Managing Complex Sample and IP Logistics in Support of Cell and Gene Therapies

Erin Schaller; Aidan Jones

PPD, part of Thermo Fisher Scientific

Digitalization

How can Life Science Technology Providers Support the Pharmaceutical Industry in the Transition Toward More Digitally Connected Operations?

Pharma's Almanac

Clinical Trials Representation

Leveraging Decentralized Clinical Trial Strategies to Reduce Health Care Disparities

Jennifer Urwongse

Commitment to ESG Principles

How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?

Pharma's Almanac

Pediatric Clinical Trials

Pediatric Clinical Trials: Considerations for Enrollment and Retention

Susan McCune, M.D.; Anusha Streubel, M.D.; Elizabeth Donahue

Roundtable

What Do You Think Was The Single Most Consequential Event Or Result In Pharma/Biopharma In 2023?

Pharma's Almanac

Sustainable Clinical Trials

Fostering a Sustainable Future in Clinical Trials through Decentralized Trial Models

Michael J. Cohen

PPD, part of Thermo Fisher Scientific

Real-World Data

How Is Your Organization Currently Leveraging Real-World Data/Evidence and What Uses Do You Anticipate in the Future?

Pharma's Almanac

Industry Wisdom

What Piece of Conventional Industry Wisdom Do You Think is Misguided, Outdated, or Just Plain Wrong?

Pharma's Almanac

Roundtable: Patient Centricity

How is an increased focus on patient-centric concerns influencing the way that you work?

Pharma's Almanac

Disruptive Technology

What do you view as the most disruptive or transformational technology or development on the horizon?

Pharma's Almanac

Decentralized Clinical Trial Design

Reducing the Challenges Sites Face when Implementing Decentralized Trials

Kamilla Posselt

PPD, part of Thermo Fisher Scientific